You are reading 1 of 2 free-access articles allowed for 30 days
The NCCP will establish the group to monitor and influence national investment in cancer research; to foster and promote a supportive environment for cancer research; and to improve co-ordination of cancer research.
The aim is to convene the group before the end of the year, a spokesperson for the NCCP told the Medical Independent.
According to minutes of the NCCP Executive Committee meeting in July, the NCCP had hoped that the group would have its first meeting in September.
At the meeting, plans to meet to discuss cancer research with Cancer Trials Ireland and the Irish Cancer Society were mentioned.
The Strategy, which was published earlier this year, notes the absence of an over-arching national framework for cancer research in Ireland.
It states there is potential for better co-ordination between different initiatives and research entities, as well as between Governmental and private agencies.
Also, research investment across different cancers may not reflect their relative incidence, it was noted.
Research priorities linked to the Strategy should be defined within the first year of the Strategy’s publication, according the document.
At its meeting in July, the NCCP also suggested that the group should examine the career progression of researchers.
It is envisaged the Health Research Board will be represented on the group, and that the newly-appointed HSE Lead for Research will also be included.